Literature DB >> 190995

A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).

K Nazerian, E A Stephens, J M Sharma, L F Lee, M Gailitis, R L Witter.   

Abstract

A continuous lymphoblastoid cell line was established from a JMV tumor transplant related to Marek's disease (MD). It is designated RPL1 (JMV) lymphoblastoid cell line. This cell line contains DNA sequences complementary to MD virus DNA and has an antigen similar to MD-tumor-associated surface antigen (MATSA). However, it lacks any MD virus (MDV) rescuable in vivo or in vitro. The cell line has surface antigens typical of chicken thymus cells (T cells) and histocompatability antigens different from those of the host chicken.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 190995

Source DB:  PubMed          Journal:  Avian Dis        ISSN： 0005-2086            Impact factor:   1.577


  17 in total

1.  A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.

Authors:  Jirí Nehyba; Radmila Hrdlicková; Joan Burnside; Henry R Bose
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines.

Authors:  B W Calnek; W R Shek; K A Schat
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

3.  Mechanism of telomerase activation by v-Rel and its contribution to transformation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.

Authors:  R Hrdlicková; J Nehyba; H R Bose
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

5.  Marek's disease virus undergoes complete morphogenesis after reactivation in a T-lymphoblastoid cell line transformed by recombinant fluorescent marker virus.

Authors:  Caroline Denesvre; Sylvie Rémy; Laetitia Trapp-Fragnet; Lorraine P Smith; Sonia Georgeault; Jean-François Vautherot; Venugopal Nair
Journal:  J Gen Virol       Date:  2015-11-26       Impact factor: 3.891

6.  Development and characterization of monoclonal antibodies to Marek's disease tumor-associated surface antigen.

Authors:  X F Liu; L F Lee
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

7.  Replication of the resident Marek's Disease virus genome in synchronized nonproducer MKT-1 cells.

Authors:  R Y Lau; M Nonoyama
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

8.  Identification and characterization of a cDNA clone derived from the Marek's disease tumour cell line RPL1 encoding a homologue of alpha-transinducing factor (VP16) of HSV-1.

Authors:  D Koptidesová; J Kopácek; V Zelník; N L Ross; S Pastoreková; J Pastorek
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

9.  Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.

Authors:  Shane C Burgess; T Fred Davison
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Circular forms of viral DNA in Marek's disease virus-transformed lymphoblastoid cells.

Authors:  H J Rziha; B Bauer
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.